Compare INBX & PCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
PIMCO CA Muni Income Fund II is a closed-ended investment company. Its investment objective is to seek to provide current income exempt from federal and California income tax. The company portfolio of investment comprises of different sector investments such as healthcare, education, property, and others.